These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16957415)

  • 21. Actual status of veralipride use.
    Carranza-Lira S
    Clin Interv Aging; 2010 Sep; 5():271-6. PubMed ID: 20852674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women.
    Verbeke K; Dhont M; Vandekerckhove D
    Maturitas; 1988 Oct; 10(3):225-30. PubMed ID: 3185294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin-secreting Pheochromocytoma Mimicking Insulin-dependent Diabetes Mellitus.
    Hirai H; Midorikawa S; Suzuki S; Sasano H; Watanabe T; Satoh H
    Intern Med; 2016; 55(20):2985-2991. PubMed ID: 27746437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACTH-secreting pheochromocytoma.
    Forman BH
    N Engl J Med; 1979 Dec; 301(25):1399. PubMed ID: 228195
    [No Abstract]   [Full Text] [Related]  

  • 25. [Adrenaline-secreting pheochromocytoma].
    Sanjuán Portugal FJ; Baila Sancho E; Faure Grima A
    Rev Clin Esp; 1999 Feb; 199(2):115-6. PubMed ID: 10216410
    [No Abstract]   [Full Text] [Related]  

  • 26. Veralipride-induced tardive dystonia in a patient with bipolar psychosis.
    Gabellini AS; Pezzoli A; De Massis P; Sacquegna T
    Ital J Neurol Sci; 1992 Oct; 13(7):621-3. PubMed ID: 1428799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study of the action of a new molecule, veralipride, on menopausal psychofunctional disorders (author's transl)].
    Delanian L
    Sem Hop; 1980 Oct; 56(37-38):1468-70. PubMed ID: 6254163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of an novel molecule, veralipride, in the treatment of menopausal disorders].
    Grall JY
    Sem Hop; 1982 Nov; 58(43):2535-7. PubMed ID: 6297046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of exclusively dopamine-secreting abdominal pheochromocytomas.
    Poirier É; Thauvette D; Hogue JC
    J Am Coll Surg; 2013 Feb; 216(2):340-6. PubMed ID: 23200795
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis of secreting pheochromocytoma].
    Bovy P; Juchmès J; Bourdon V; Smeets JP; Cession-Fossion A; Godon JP; Siquet R; Rahman M; Rorive G; Lecomte J
    Rev Med Liege; 1980 Nov; 35(21):724-9. PubMed ID: 7455452
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adrenal incidentaloma: a dopamine-secreting pheochromocytoma with an atypical clinical picture. A case report and review of the literature].
    Bartolacci M; Bartolacci S; Leombruni E; Annunziata A; Di Rienzo M; Picardi N
    Ann Ital Chir; 1998; 69(6):805-14. PubMed ID: 10213955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A multicenter comparison of veralipride versus placebo in the vasomotor flushes of menopause. An evaluation of the prolonged effect].
    Boulot P; Viala JL
    Rev Fr Gynecol Obstet; 1988 Dec; 83(12):823-7. PubMed ID: 3064254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study.
    Vercellini P; Sacerdote P; Trespidi L; Manfredi B; Panerai AE; Crosignani PG
    Fertil Steril; 1994 Nov; 62(5):938-42. PubMed ID: 7926138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low specificity of urinary 3-methoxytyramine in screening of dopamine-secreting pheochromocytomas and paragangliomas.
    Patin F; Crinière L; Francia T; Kassem S; Pierre P; Bruno C; Vayne C; Vourc'h P; Benz-de Bretagne I; Andres CR; Blasco H
    Clin Biochem; 2016 Oct; 49(15):1205-1208. PubMed ID: 27208558
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pheochromocytoma secreting adrenaline, a rare form of presentation].
    Escobedo Palau JA; Chena Alejandro JA; Rubio Félix SA; Aznar Carbonell A; Sebastián Royo B; Fernández García A
    An Med Interna; 1994 Feb; 11(2):80-2. PubMed ID: 8193239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-hormonal therapy for menopausal disorders: results of a multicentric double-blind trial (author's transl)].
    Linquette M; Rivière J; Vague J
    Sem Hop; 1980 Oct; 56(37-38):1445-8. PubMed ID: 6254159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study of veralipride in menopausal sudden flushes (author's transl)].
    Wesel S; L'Hermite M
    Sem Hop; 1980 Oct; 56(37-38):1465-7. PubMed ID: 6254162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A clinical trial of veralipride in menopausal complaints (author's transl)].
    Lefevre J
    Sem Hop; 1982 Feb; 58(7):411-3. PubMed ID: 6280313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonidine-suppression test in epinephrine secreting pheochromocytoma: report of a case.
    Dupont AG; Vanderniepen P; Gerlo E; Somers G; Vanhaelst L; in't Veld P; Gepts W; Sacre R; Six RO
    J Endocrinol Invest; 1985 Apr; 8(2):153-6. PubMed ID: 4031382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis of hyperfunctioning adrenal masses].
    Horger M; Fritz J; Bares R; Müssig K
    Rofo; 2006 Dec; 178(12):1171-6. PubMed ID: 17396301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.